ASX 200
Checkout Our Recommendations for free - 7 day free trial Subscribe Now

Gilead Sciences Inc - GILD share price

Current Price: $ - -
Updated At: -

About

Gilead Sciences, Inc. is a biopharmaceutical company specializing in medicines for HIV, viral hepatitis, and cancer. Key products include those for HIV treatment, COVID-19 (Veklury), oncology cell therapies (Tecartus, Yescarta), and treatments for liver diseases. The company also develops small molecule inhibitors for oncology and inflammatory diseases.

Company Profile

Market Cap: -
Enterprise Value: -
Shares Outstanding: -
Shares Float: -
P/E Ratio: -
PEG Ratio: -
Book Value: -
Revenue TTM: -
Div Yield: -
Earning Share: -
Dividend per Share: -
Profit Margin: -

Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.

Top Shareholders

Price Summary

Today's High -
Price High
Today's Low -
Price Low
52 Week High: -
Price High
52 Week Low: -
Price Low
Price High
Week's High: -
Price Low
Week's Low: -

Price Chart

Get Your FREE Report

Discover the Top ASX Stocks to Invest In 2026!

Expert Analysis of Top-Performing ASX Stocks

Market Insights and In-Depth Research

Buy, Sell, And Hold Recommendations

Almost There!

Enter your details to download the report

Success!

Preparing your download...

Latest Reports from Veye

Grab Your FREE Report on Top 5 ASX Stocks to Buy in 2026